A Singlet Oxygen Self-Reporting Photosensitizer for Cancer Phototherapy.

Tao Xiong,Mingle Li,Yingchao Chen,Jianjun Du,Jiangli Fan,Xiaojun Peng

DOI: https://doi.org/10.1039/d0sc05495j

IF: 8.4

2021-01-01

Chemical Science

Abstract:Photodynamic cancer therapy has attracted great attention with the increasing threat of tumors, and improving its therapeutic efficacy is highly desirable.

What problem does this paper attempt to address?

Delivering Singlet Oxygen in Dark Condition with an Anthracene-Functionalized Semiconducting Compound for Enhanced Phototheranostics

Jian Shen,Liuhong Pan,Xujing Zhang,Zhenyuan Zou,Bo Wei,Yongchang Chen,Xiaoyan Tang,Dengfeng Zou

DOI: https://doi.org/10.3389/fbioe.2022.781766

IF: 5.7

2022-01-01

Frontiers in Bioengineering and Biotechnology

Abstract:Photodynamic therapy (PDT) utilizes the photogeneration of reactive oxygen species (ROS) with high cytotoxicity to kill cancer cells, holding great promise for cancer treatment. Fractionated delivery of singlet oxygen (1O2) is a wise approach to relieving hypoxia, thus enhancing the therapeutic efficacy. In this article, an anthracene-functionalized semiconducting compound (DPPA) has been designed and synthesized. With irradiation, the compound is able to undergo efficient intersystem crossing (ISC) and non-radioactive decay for photodynamic/photothermal synergistic therapy. In addition, the anthracene module is able to capture and release 1O2 reversibly with or without irradiation. DPPA nanoparticles (NPs) obtained by nanoprecipitation with DSPE-PEG exhibit considerable high phototoxicity on human kidney cancer cells (A498), and the half maximum inhibitory concentration (IC50) is 15.8 μg/ml. Furthermore, an in vivo study demonstrates that complete tumor suppression was observed when the mice were administered DPPA NPs with the help of laser, compared with the control and dark groups. The H&E analysis of the normal tissues (the heart, liver, spleen, lungs, and kidney) indicates that such NPs cause no side effects, indicating the biosafety of DPPA NPs. The results provide a strategy to design a heavy-atom–free photosensitizer for photothermal and fractionated PDT against kidney tumors.
New Cy5 Photosensitizers for Cancer Phototherapy: a Low Singlet-Triplet Gap Provides High Quantum Yield of Singlet Oxygen.

He Ma,Saran Long,Jianfang Cao,Feng Xu,Panwang Zhou,Guang Zeng,Xiao Zhou,Chao Shi,Wen Sun,Jianjun Du,Keli Han,Jiangli Fan,Xiaojun Peng

DOI: https://doi.org/10.1039/d1sc04570a

IF: 8.4

2021-01-01

Chemical Science

Abstract:Highly efficient triplet photosensitizers (PSs) have attracted increasing attention in cancer photodynamic therapy where photo-induced reactive oxygen species (ROSs, such as singlet oxygen) are produced via singlet-triplet intersystem crossing (ISC) of the excited photosensitizer to kill cancer cells. However, most PSs exhibit the fatal defect of a generally less-than-1% efficiency of ISC and low yield of ROSs, and this defect strongly impedes their clinical application. In the current work, a new strategy to enhance the ISC and high phototherapy efficiency has been developed, based on the molecular design of a thio-pentamethine cyanine dye (TCy5) as a photosensitizer. The introduction of an electron-withdrawing group at the meso-position of TCy5 could dramatically reduce the singlet-triplet energy gap (ΔE st) value (from 0.63 eV to as low as 0.14 eV), speed up the ISC process (τ ISC = 1.7 ps), prolong the lifetime of the triplet state (τ T = 319 μs) and improve singlet oxygen (1O2) quantum yield to as high as 99%, a value much higher than those of most reported triplet PSs. Further in vitro and in vivo experiments have shown that TCy5-CHO, with its efficient 1O2 generation and good biocompatibility, causes an intense tumor ablation in mice. This provides a new strategy for designing ideal PSs for cancer photo-therapy.
Singlet Oxygen in Photodynamic Therapy

Shengdong Cui,Xingran Guo,Sen Wang,Zhe Wei,Deliang Huang,Xianzeng Zhang,Timothy C. Zhu,Zheng Huang

DOI: https://doi.org/10.3390/ph17101274

IF: 4.6

2024-09-27

Pharmaceuticals

Abstract:Photodynamic therapy (PDT) is a therapeutic modality that depends on the interaction of light, photosensitizers, and oxygen. The photon absorption and energy transfer process can lead to the Type II photochemical reaction of the photosensitizer and the production of singlet oxygen (1O2), which strongly oxidizes and reacts with biomolecules, ultimately causing oxidative damage to the target cells. Therefore, 1O2 is regarded as the key photocytotoxic species accountable for the initial photodynamic reactions for Type II photosensitizers. This article will provide a comprehensive review of 1O2 properties, 1O2 production, and 1O2 detection in the PDT process. The available 1O2 data of regulatory-approved photosensitizing drugs will also be discussed.

pharmacology & pharmacy,chemistry, medicinal
A Self-Reporting AIE Probe with a Built-in Singlet Oxygen Sensor for Targeted Photodynamic Ablation of Cancer Cells

Youyong Yuan,Chong-Jing Zhang,Shidang Xu,Bin Liu

DOI: https://doi.org/10.1039/c5sc03583j

IF: 8.4

2016-01-01

Chemical Science

Abstract:A probe for the in situ monitoring of singlet oxygen generation during targeted theranostic photodynamic therapy is developed based on a photosensitizer with aggregation-induced emission (AIE) characteristics and conjugated to a fluorogenic rhodol dye via a singlet oxygen cleavable linker.
A unique self-reporting photosensitizer enabling simultaneous photodynamic therapy and real-time monitoring of phototheranostic process in a dynamic dual-color mode

Dong-Hui Wang,Li-Jian Chen,Xu Zhao,Xiu-Ping Yan

DOI: https://doi.org/10.1039/d1tb02097h

IF: 7.571

2021-01-01

Journal of Materials Chemistry B

Abstract:A unique self-reporting photosensitizer enables simultaneous PDT and real-time monitoring phototheranostic process in a dynamic dual-color mode, showing its great potential as a multifunctional drug for cancer theranostics.

materials science, biomaterials
Recent progress in the development of singlet oxygen carriers for enhanced photodynamic therapy

Guo Li,Mingmin Wu,Yongxiao Xu,Qi Wang,Jinxia Liu,Xiaobo Zhou,Haiwei Ji,Qu Tang,Xijuan Gu,Shujuan Liu,Yuling Qin,Li Wu,Qiang Zhao

DOI: https://doi.org/10.1016/j.ccr.2022.214979

IF: 24.833

2022-12-22

Coordination Chemistry Reviews

Abstract:Hypoxia is a significant feature of the tumor, which has been proved to be the major challenge in translating photodynamic therapy (PDT) into clinical applications. To solve this issue, singlet oxygen carriers have been used to relieve tumor hypoxia and accordingly improve the therapeutic effect of PDT. Herein, a systematic summary of recent progress in the design and preparation of singlet oxygen carriers to overcome the hypoxia issue and realize the enhanced PDT is presented. For discussing purpose, the typical molecular backbone applied for the design and fabrication of an intelligent singlet oxygen carrier is firstly discussed, with an emphasis on the mechanism interpretation of the reversible trap and release of singlet oxygen. Furthermore, the enhanced PDT realized by innovative singlet oxygen carriers is systematically discussed in detail, including therapeutic platforms based on naphthalenes, anthracenes, and pyridines-derived small molecules or polymers. Finally, some critical points for singlet oxygen carrier design and an outlook for the future research and development of this promising field are provided. We sincerely anticipate the information presented in this review to provide insightful design guidelines for the further development of precise and efficient antitumor application systems based on the singlet oxygen carrier.

chemistry, inorganic & nuclear
Enhanced Singlet Oxygen Yield of Photosensitizer by Gold Nanoparticles

SHEN Lijian,XU Hao,WANG Sijia,ZHANG Zhenxi

DOI: https://doi.org/10.3969/j.issn.1007-7146.2012.05.001

2012-01-01

Abstract:Photodynamic therapy,a minimally invasive cancer treatment modality,has proven to have low morbidity and good tolerance.It includes the administration of a photosensitive drug and subsequent irradiation with appropriate light to produce singlet oxygen for the destruction of cells.At present,researchers have carried out a lot of work to improve the efficacy of photosensitizer on photodynamic therapy.Biocompatible gold nanoparticles that exhibit surface-plasmon resonance have been used as drug-delivery carriers or tools for tumor detection.
Two-Dimensional Singlet Oxygen Imaging with Its Near-Infrared Luminescence During Photosensitization

Bolin Hu,Nan Zeng,Zhiyi Liu,Yanhong Ji,Weidong Xie,Qing Peng,Yong Zhou,Yonghong He,Hui Ma

DOI: https://doi.org/10.1117/1.3528593

IF: 3.758

2011-01-01

Journal of Biomedical Optics

Abstract:Photodynamic therapy is a promising cancer treatment that involves activation of photosensitizer by visible light to create singlet oxygen. This highly reactive oxygen species is believed to induce cell death and tissue destruction in PDT. Our approach used a near-infrared area CCD with high quantum efficiency to detect singlet oxygen by its 1270-nm luminescence. Two-dimensional singlet oxygen images with its near-infrared luminescence during photosensitization could be obtained with a CCD integration time of 1 s, without scanning. Thus this system can produce singlet oxygen luminescence images faster and achieve more accurate measurements in comparison to raster-scanning methods. The experimental data show a linear relationship between the singlet oxygen luminescence intensity and sample concentration. This method provides a detection sensitivity of 0.0181 μg∕ml (benzoporphyrin derivative monoacid ring A dissolved in ethanol) and a spatial resolution better than 50 μm. A pilot study was conducted on a total of six female Kunming mice. The results from this study demonstrate the system's potential for in vivo measurements. Further experiments were carried out on two tumor-bearing nude mice. Singlet oxygen luminescence images were acquired from the tumor-bearing nude mouse with intravenous injection of BPD-MA, and the experimental results showed real-time singlet oxygen signal depletion as a function of the light exposure.
Nano-photosensitizer Based on Layered Double Hydroxide and Isophthalic Acid for Singlet Oxygenation and Photodynamic Therapy

Rui Gao,Xuan Mei,Dongpeng Yan,Ruizheng Liang,Min Wei

DOI: https://doi.org/10.1038/s41467-018-05223-3

IF: 16.6

2018-01-01

Nature Communications

Abstract:Singlet oxygen has won a great deal of attention to catalysis and biological studies due to its strong oxidizing properties. However, the photosensitizers which require for the generation of singlet oxygen remain inadequate because of their lack of long-wavelength absorption, weak hydrophilicity, and poor biocompatibility. Here, we develop near-infrared laser activated supramolecular photosensitizers (isophthalic acid/layered double hydroxide nanohybrids) for efficient two-photon photodynamic therapy. The singlet oxygen quantum yield of nanohybrid is up to 0.74. Critically, in vitro tests verify the superior anti-cancer properties of nanohybrid with an IC 50 determine to be 0.153 μg mL −1 . The nanohybrids take advantage of the superior tissue penetration of 808 nm laser irradiation and exhibit a dramatically strong ability to ablate tumors in vivo, with extremely low toxicity. This work provides the proof of concept that ultralong-lived triplet excitons can function as two-photon-activated photosensitizers for an effective singlet oxygen generation.
A New Insight into the Singlet Oxygen Mechanism for Photodynamic Therapy

Meng Kou,Feng Qin,Weiming Lü,Zheng Hu,Zhiguo Zhang,Weiming Lü

DOI: https://doi.org/10.1021/acs.jpclett.3c01197

2023-06-13

Abstract:Modern photodynamic therapy has been built on the mechanism of the interaction between the photosensitizer (porphyrin derivatives) and oxygen to produce singlet oxygen, which relies on energy transfer from the triplet excited state (T(1)) of porphyrin to the excited state of oxygen. In this process, the energy transfer from the singlet excited state (S(1)) of porphyrin to oxygen is believed to be not pronounced as the rapid decay of S(1) and the large energy mismatch. Here, we have evidenced the...

chemistry, physical,physics, atomic, molecular & chemical,nanoscience & nanotechnology,materials science, multidisciplinary
Two-Photon Triplet Photosensitizers for Production of Singlet Oxygen

Li Hongru,Xie Ting,Hu Nüdan,Yang Liufeng,Zhang Shengtao,Gao Fang

2009-01-01

Progress in chemistry

Abstract:Since 2001, some progress has been made on the development of two-photon triplet photosensitizers which can be employed for the production of singlet oxygen. These sensitizers have great application potential as photodynamic therapy pharmaceuticals for the treatment of tumor tissue under near-IR and IR laser. This paper emphasizes the analysis of category of the two-photon triplet sensitizers which have been developed in recent years, such as hydrophobic and water-soluble sensitizers. This paper also describes how to control the properties of two-photon sensitizers and quantum yields of singlet oxygen of sensitizers with chemical approach based on the properties of the excited states of the sensitizers. The measurement of relative and absolute two-photon absorption cross sections of the sensitizers is generalized. Some significant problems on the development of two-photon triplet sensitizers are summarized. Furthermore, the prospectives on the research of the two-photon triplet sensitizers are discussed as well in this paper.
Self-reported and self-facilitated theranostic oxygen nano-economizer for precise and hypoxia alleviation-potentiated photodynamic therapy

Shumeng Li,Fujun Yang,Yongdan Wang,Linshan Jia,Xiaohong Hou

DOI: https://doi.org/10.1039/d3mh01244a

2023-11-27

Abstract:Photodynamic therapy (PDT) has been extensively investigated for cancer treatment by virtue of singlet oxygen-induced oxidative damage to tumors. Nevertheless, the therapeutic efficiency of PDT is still limited by the low singlet oxygen yield attributed to the improper irradiation duration and the tumor hypoxic microenvironment. To tackle these challenges, we elaborately design a theranostic oxygen nano-economizer to self-report the optimal irradiation duration and alleviate tumor hypoxia simultaneously, which is engineered by fluorescent 9,10-anthracenyl bis (benzoic acid) (DPA)-MOF, tetrakis (4-carboxyphenyl) porphyrin (TCPP), triphenyl phosphine (TPP) and redox-responsive lipid-PEG (DSPE-SS-PEG2k). Upon laser irradiation, the fluorescence of DPA-MOF could be quenched, thereby self-reporting the optimal irradiation duration for sufficient PDT. The decoration of DSPE-SS-PEG2k and TPP endows the theranostic oxygen nano-economizer with a tumor-specific response and mitochondrial targeting capability, respectively. Notably, singlet oxygen generated from TCPP reduces oxygen consumption by disrupting the entire oxidative phosphorylation (OXPHOS) pathway in the mitochondria of tumor cells, further improving the level of singlet oxygen in a self-facilitated manner for hypoxia alleviation-potentiated PDT. As expected, such a self-reported and self-facilitated theranostic oxygen nano-economizer exhibits potent antitumor activity in the 4T1 tumor-bearing mouse model. This study offers a theranostic paradigm for precise and hypoxia alleviation-potentiated cancer therapy.
Diketopyrrolopyrrole-Au(I) As Singlet Oxygen Generator for Enhanced Tumor Photodynamic and Photothermal Therapy

Xiaoyu Huang,Rui Gu,Jiewei Li,Nan Yang,Zijin Cheng,Weili Si,Peng Chen,Wei Huang,Xiaochen Dong

DOI: https://doi.org/10.1007/s11426-019-9531-4

2020-01-01

Science China Chemistry

Abstract:Diketopyrrolopyrrole (DPP) derivatived photosensitizers (PSs) with near infrared (NIR) absorption and good photophysical properties have drawn tremendous attention in cancer phototherapy. However, current DPP derivatives present unsatisfactory quantum yield of singlet oxygen (1O2) due to the large energy gap between the excited singlet and triplet states. To tackle this challenge, herein the DPP core is functionalized with triphenylphosphine-Au(I) group (ThDPP-Au), leading to a high 1O2 quantum yield of 0.65. Theoretical calculation attributes the enhancement to spin-orbit coupling and population of the triplet excition upon photoexcitation. The hydrophilic ThDPP-Au nanoparticals (NPs) are prepared via nano-reprecipitation, which displays homogeneous size and excellent light absorption ability (ε=4.382×104 M−1 cm−1). And the ThDPP-Au NPs exhibit low dark toxicity and high phototoxicity, which can effectively kill tumor cells via 1O2 induced mitochondrial apoptotic pathway upon irradiation. Furthermore, in vivo experiments demonstrate that ThDPP-Au NPs can selective accumulation in tumor and present excellent synergistic photodynamic/photothermal therapy guided by fluorescence and photothermal dual imaging.
Controllable Photodynamic Therapy Implemented by Regulating Singlet Oxygen Efficiency

Wenting Wu,Xiaodong Shao,Jianzhang Zhao,Mingbo Wu

DOI: https://doi.org/10.1002/advs.201700113

IF: 15.1

2017-01-01

Advanced Science

Abstract:With singlet oxygen (O-1(2)) as the active agent, photodynamic therapy (PDT) is a promising technique for the treatment of various tumors and cancers. But it is hampered by the poor selectivity of most traditional photosensitizers (PS). In this review, we present a summary of controllable PDT implemented by regulating singlet oxygen efficiency. Herein, various controllable PDT strategies based on different initiating conditions (such as pH, light, H2O2 and so on) have been summarized and introduced. More importantly, the action mechanisms of controllable PDT strategies, such as photoinduced electron transfer (PET), fluorescence resonance energy transfer (FRET), intramolecular charge transfer (ICT) and some physical/chemical means (e.g. captivity and release), are described as a key point in the article. This review provide a general overview of designing novel PS or strategies for effective and controllable PDT.
Singlet oxygen-responsive micelles for enhanced photodynamic therapy

Xiaodan Li,Min Gao,Keting Xin,Ling Zhang,Dan Ding,Deling Kong,Zheng Wang,Yang Shi,Fabian Kiessling,Twan Lammers,Jianjun Cheng,Yanjun Zhao

DOI: https://doi.org/10.1016/j.jconrel.2017.05.025

IF: 11.467

2017-01-01

Journal of Controlled Release

Abstract:Photodynamic therapy (PDT) efficacy is limited by the very short half-life and limited diffusion radius of singlet oxygen (1O2). We report a 1O2-responsive micellar nanoplatform subject to considerable size-expansion upon light triggering to facilitate on-demand release of photosensitizers. Imidazole, a well-known 1O2 scavenger, was incorporated in the hydrophobic core of amphiphilic copolymer micelles, and was used to coordinate with biocompatible Zn2+ and encapsulate the photosensitizer chlorin e6 (Ce6). The micelles are highly sensitive to light irradiation: 1O2 triggering induced dramatic particle size expansion due to the conversion of imidazole to hydrophilic urea, resulting in instantaneous release of Ce6 and rapid intracellular distribution. This 1O2-responsive, size-expandable nanosystem delivered substantially more Ce6 to tumor sites as compared to free Ce6, and exhibited improved anti-tumor efficacy in vivo in 4T1 tumor-bearing mice. This work opens new avenues of particle expansion-induced PDT enhancement by controlled imidazole chemistry.
Molecular Engineering of Pure Superoxide Radical Photogenerator for Hypoxia-Tolerant Tumor Theranostics

Jipeng Ding,Tianyu Zhu,Fan Zheng,Feng Gao,Shengwang Zhang,Kexiang Zhang,Jinrong Zeng,Jie Dong,Wenbin Zeng

DOI: https://doi.org/10.1002/smll.202405164

IF: 13.3

2024-08-24

Small

Abstract:Photodynamic therapy (PDT) is a promising cancer treatment, but limited oxygen supply in tumors (hypoxia) can hinder its effectiveness. This is because traditional PDT relies on Type-II reactions that require oxygen. Type-I photosensitizers (PSs) offer a promising approach to overcome the limitations of tumor photodynamic therapy (PDT) in hypoxic environments. To leverage the advantages of Type-I PDT, the design and evaluation of a series of Type-I PSs for developing pure Type-1 PSs, by incorporating benzene, thiophene, or bithiophene into the donor-acceptor molecular skeleton are reported. Among them, CTTI (with bithiophene) shows the best performance, generating the most superoxide radical (O2 •-) upon light irradiation. Importantly, CTTI exclusively produced superoxide radicals, avoiding the less effective Type-II pathway. This efficiency is due to CTTI's energy gap and low reduction potential, which favor electron transfer to oxygen for O2 •- generation. Finally, CTTI NPs are successfully fabricated by encapsulating CTTI into liposomes, and validated to be effective in killing tumor cells, even under hypoxic conditions, making them promising hypoxia-tolerant tumor phototheranostic agents in both in vitro and in vivo applications.
Targeted Endoperoxides Delivering Singlet Oxygen to Cancer Cell Mitochondria: Exploration of the Therapeutic Potential

Ziang Liu,Lei Wang,Rensong Sun,Hao Wu,Yang Wang,Shengli Zhang,Guangzhe Li,Kun Shao,Engin Umut Akkaya

DOI: https://doi.org/10.1002/chem.202401277

2024-06-09

Chemistry - A European Journal

Abstract:The clinical practice of photodynamic therapy of cancer (PDT) is mostly limited to superficial types of skin cancer. The major reason behind this limited applicability is the need for light in the photogeneration of ROS, and in particular singlet oxygen. In order to circumvent this major roadblock, we designed and synthesized naphthalene‐derived endoperoxides with mitochondria targeting triphenylphosphonium moieties. Here, we show that these compounds release singlet oxygen by thermal cycloreversion, and initiate cell death with IC50 < 10 μM in cancer cell cultures. The mouse 4T1 breast tumor model study, where the endoperoxide compound was introduced intraperitoneally, also showed highly promising results, with negligible systemic toxicity. Targeted delivery of singlet oxygen to cancer cell mitochondria could be the breakthrough needed to transform Photodynamic Therapy into a broadly applicable methodology for cancer treatment by keeping the central tenet and discarding problematic dependencies on oxygen or external light.

chemistry, multidisciplinary
Enhancing singlet oxygen generation in semiconducting polymer nanoparticles through fluorescence resonance energy transfer for tumor treatment

Jiayang Jiang,Yuanyuan Qian,Zihan Xu,Zhuang Lv,Peng Tao,Mingjuan Xie,Shujuan Liu,Wei Huang,Qiang Zhao

DOI: https://doi.org/10.1039/c8sc05501g

2019-04-11

Abstract:Photosensitizers (PSs) are of particular importance for efficient photodynamic therapy (PDT). Challenges for PSs simultaneously possessing strong light-absorbing ability, high 1O2 generation by effective intersystem crossing from the singlet to the triplet state, good water-solubility and excellent photostability still exist. Reported here are a new kind of dual-emissive semiconducting polymer nanoparticles (SPNs) containing fluorescent BODIPY derivatives and near-infrared (NIR) phosphorescent iridium(iii) complexes. In the SPNs, the BODIPY units serve as the energy donors in the fluorescence resonance energy transfer (FRET) process for enhancing the light absorption of the SPNs. The NIR emissive iridium(iii) complexes are chosen as the energy acceptors and efficient photosensitizers. The ionized semiconducting polymers can easily self-assemble to form hydrophilic nanoparticles and homogeneously disperse in aqueous solution. Meanwhile, the conjugated backbone of SPNs provides effective shielding for the two luminophores from photobleaching. Thus, an excellent overall performance of the SPN-based PSs has been realized and the high 1O2 yield (0.97) resulting from the synergistic effect of BODIPY units and iridium(iii) complexes through the FRET process is among the best reported for PSs. In addition, owing to the phosphorescence quenching of iridium(iii) complexes caused by 3O2, the SPNs can also be utilized for O2 mapping in vitro and in vivo, which assists in the evaluation of the PDT process and provides important instructions in early-stage cancer diagnosis.
Observation of Singlet Oxygen with Single-Molecule Photosensitization by Time-Dependent Photon Statistics.

Yao Li,Ruiyun Chen,Haitao Zhou,Ying Shi,Chengbing Qin,Yajun Gao,Guofeng Zhang,Yan Gao,Liantuan Xiao,Suotang Jia

DOI: https://doi.org/10.1021/acs.jpclett.8b02088

2018-01-01

Abstract:The singlet oxygen has been widely applied to the treatment of physiological diseases, and the photosensitized generation of singlet oxygen is the main means of its physiological applications. On the basis of the fluctuation of fluorescence field from single photosensitizer, we characterize the generation of singlet oxygen at single molecule level with the time-dependent photon statistical method. By measuring the time-tagged-time-resolved single-molecule fluorescence photons, we analyze the time-dependent Mandel-Q parameter, which has been performed at different oxygen environment. It is shown that the single molecule not only offers an efficient way of generating singlet oxygen in ambient condition but also provides insights for the fluctuation of singlet oxygen in the nanoscale environment. The method of time-dependent photon statistics provides a convenient methodology for observing photosensitizers generating singlet oxygen in real time at single photosensitizer level.
A Novel Theranostic Nanoprobe for in Vivo Singlet Oxygen Detection and Real-Time Dose-Effect Relationship Monitoring in Photodynamic Therapy

Han Wang,Zhaohui Wang,Yongkuan Li,Tian Xu,Qi Zhang,Man Yang,Peng Wang,Yueqing Gu

DOI: https://doi.org/10.1002/smll.201902185

IF: 13.3

2019-01-01

Small

Abstract:Singlet oxygen, as the main member of reactive oxygen species, plays a significant role in cancer photodynamic therapy. However, the in vivo real-time detection of singlet oxygen remains challenging. In this work, a Forster resonance energy transfer (FRET)-based upconversion nanoplatform for monitoring the singlet oxygen in living systems is developed, with the ability to evaluate the in vivo dose-effect relationship between singlet oxygen and photodynamic therapy (PDT) efficacy. In details, this nanoplatform is composed of core-shell upconversion nanoparticles (UCNPs), photosensitizer MC540, NIR dye IR-820, and poly(acryl amine) PAA-octylamine, where the UCNPs serve as an energy donor while IR-820 serves as an energy acceptor. The nanoparticles are found to sensitively reflect the singlet oxygen levels generated in the tumor tissues during PDT, by luminescence intensity changes of UNCPs at 800 nm emission. Furthermore, it could also enable tumor treatment with satisfactory biocompatibility. To the best knowledge, this is the first report of a theranostic nanoplatform with the ability to formulate the in vivo dose-effect relationship between singlet oxygen and PDT efficacy and to achieve tumor treatment at the same time. This work might also provide an executable strategy to evaluate photodynamic therapeutic efficacy based on singlet oxygen pathway.

A Singlet Oxygen Self-Reporting Photosensitizer for Cancer Phototherapy.

Delivering Singlet Oxygen in Dark Condition with an Anthracene-Functionalized Semiconducting Compound for Enhanced Phototheranostics

New Cy5 Photosensitizers for Cancer Phototherapy: a Low Singlet-Triplet Gap Provides High Quantum Yield of Singlet Oxygen.

Singlet Oxygen in Photodynamic Therapy

A Self-Reporting AIE Probe with a Built-in Singlet Oxygen Sensor for Targeted Photodynamic Ablation of Cancer Cells

A unique self-reporting photosensitizer enabling simultaneous photodynamic therapy and real-time monitoring of phototheranostic process in a dynamic dual-color mode

Recent progress in the development of singlet oxygen carriers for enhanced photodynamic therapy

Enhanced Singlet Oxygen Yield of Photosensitizer by Gold Nanoparticles

Two-Dimensional Singlet Oxygen Imaging with Its Near-Infrared Luminescence During Photosensitization

Nano-photosensitizer Based on Layered Double Hydroxide and Isophthalic Acid for Singlet Oxygenation and Photodynamic Therapy

A New Insight into the Singlet Oxygen Mechanism for Photodynamic Therapy

Two-Photon Triplet Photosensitizers for Production of Singlet Oxygen

Self-reported and self-facilitated theranostic oxygen nano-economizer for precise and hypoxia alleviation-potentiated photodynamic therapy

Diketopyrrolopyrrole-Au(I) As Singlet Oxygen Generator for Enhanced Tumor Photodynamic and Photothermal Therapy

Controllable Photodynamic Therapy Implemented by Regulating Singlet Oxygen Efficiency

Singlet oxygen-responsive micelles for enhanced photodynamic therapy

Molecular Engineering of Pure Superoxide Radical Photogenerator for Hypoxia-Tolerant Tumor Theranostics

Targeted Endoperoxides Delivering Singlet Oxygen to Cancer Cell Mitochondria: Exploration of the Therapeutic Potential

Enhancing singlet oxygen generation in semiconducting polymer nanoparticles through fluorescence resonance energy transfer for tumor treatment

Observation of Singlet Oxygen with Single-Molecule Photosensitization by Time-Dependent Photon Statistics.

A Novel Theranostic Nanoprobe for in Vivo Singlet Oxygen Detection and Real-Time Dose-Effect Relationship Monitoring in Photodynamic Therapy